Federal Register / Vol. 75, No. 241 / Thursday, December 16, 2010 / Notices 78705 

also be viewed on the Commission’s 

Web site at http://www.ferc.gov using 

the ‘‘eLibrary’’ link. Enter the docket 

number excluding the last three digits in 

the docket number field to access the 

document. For assistance, contact FERC 

Online Support at 

FERCOnlineSupport@ferc.gov or tollfree at 1–866–208–3676, or for TTY, 

(202) 502–8659. 

Kimberly D. Bose, 

Secretary. 

[FR Doc. 2010–31565 Filed 12–15–10; 8:45 am] 

BILLING CODE 6717–01–P 

FEDERAL ACCOUNTING STANDARDS 

ADVISORY BOARD 

Issuance of Exposure Drafts on 

Implementation Guidance on the 

Accounting for the Disposal of G– 

PP&E and Implementation Guidance 

for Estimating the Historical Cost of G– 

PP&E 

AGENCY: Federal Accounting Standards 

Advisory Board. 

ACTION: Notice. 

Board Action: Pursuant to 31 U.S.C. 

3511(d), the Federal Advisory 

Committee Act (Pub. L. 92–463), as 

amended, and the FASAB Rules of 

Procedure, as amended in October, 

2010, notice is hereby given that the 

Accounting and Auditing Policy 

Committee (AAPC) has issued two new 

Federal Financial Accounting Technical 

Release exposure drafts entitled 

Implementation Guidance on the 

Accounting for the Disposal of G–PP&E 

and Implementation Guidance for 

Estimating the Historical Cost of G– 

PP&E. 

The Exposure Drafts are available on 

the FASAB home page http:// 

www.fasab.gov/exposure.html. Copies 

can be obtained by contacting FASAB at 

(202) 512–7350. 

Respondents are encouraged to 

comment on any part of the exposure 

draft. Written comments are requested 

by February 11, 2011, and should be 

sent to: Wendy M. Payne, Executive 

Director, Federal Accounting Standards 

Advisory Board, 441 G Street, NW., 

Suite 6814, Mail Stop 6K17V, 

Washington, DC 20548. 

FOR FURTHER INFORMATION CONTACT: 

Wendy Payne, Executive Director, at 

(202) 512–7350. 

Authority: Federal Advisory Committee 

Act, Public Law 92–463. 

Dated: December 10, 2010. 

Charles Jackson, 

Federal Register Liaison Officer. 

[FR Doc. 2010–31538 Filed 12–15–10; 8:45 am] 

BILLING CODE 1610–02–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y 

(12 CFR 225.41) to acquire shares of a 

bank or bank holding company. The 

factors that are considered in acting on 

the notices are set forth in paragraph 7 

of the Act (12 U.S.C. 1817(j)(7)). 

The notices are available for 

immediate inspection at the Federal 

Reserve Bank indicated. The notices 

also will be available for inspection at 

the offices of the Board of Governors. 

Interested persons may express their 

views in writing to the Reserve Bank 

indicated for that notice or to the offices 

of the Board of Governors. Comments 

must be received not later than January 

3, 2011. 

A. Federal Reserve Bank of Kansas 

City (Dennis Denney, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001: 

1. Jeffrey J. Heiman and Jerod J. 

Heiman, both of Wichita, Kansas; to 

retain control of Norcon Financial 

Corp., and thereby indirectly retain 

control of Conway Bank, National 

Association, both in Conway Springs, 

Kansas. 

Board of Governors of the Federal Reserve 

System, December 13, 2010. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 2010–31618 Filed 12–15–10; 8:45 am] 

BILLING CODE 6210–01–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The application also will be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than January 10, 

2011. 

A. Federal Reserve Bank of Dallas 

(E. Ann Worthy, Vice President) 2200 

North Pearl Street, Dallas, Texas 75201– 

2272: 

1. Connemara Bancorp, Inc., Dallas, 

Texas; to become a bank holding 

company by acquiring 100 percent of 

the voting shares of First Amherst 

Bancshares, Inc., and thereby indirectly 

acquire voting shares of First National 

Bank, both in Amherst, Texas. 

Board of Governors of the Federal Reserve 

System, December 13, 2010. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 2010–31617 Filed 12–15–10; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3241–N] 

Medicare Program; Request for 

Nominations for Members for the 

Medicare Evidence Development & 

Coverage Advisory Committee 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

request for nominations for 

consideration for membership on the 

Medicare Evidence Development & 

Coverage Advisory Committee 

(MEDCAC). Among other things, the 

MEDCAC advises the Secretary of the 


srobinson on DSKHWCL6B1PROD with NOTICES
78706 Federal Register / Vol. 75, No. 241 / Thursday, December 16, 2010 / Notices 

Department of Health and Human 

Services (the Secretary) and the 

Administrator of the Centers for 

Medicare & Medicaid Services (CMS), as 

requested by the Secretary, whether 

medical items and services are 

‘‘reasonable and necessary’’ and 

therefore eligible for coverage under 

Title XVIII of the Social Security Act. 

We are requesting nominations for 

both voting and nonvoting members to 

serve on the MEDCAC. Nominees are 

selected based upon their individual 

qualifications and not as representatives 

of professional associations or societies. 

We have a special interest in ensuring 

that the interests of both women and 

men, members of all racial and ethnic 

groups, and physically challenged 

individuals are adequately represented 

on the MEDCAC. Therefore, we 

encourage nominations of qualified 

candidates who can represent these 

interests. 

The MEDCAC reviews and evaluates 

medical literature, reviews technology 

assessments, and examines data and 

information on the effectiveness and 

appropriateness of medical items and 

services that are covered or eligible for 

coverage under Medicare. 

DATES: Nominations will be considered 

if postmarked by Monday, January 31, 

2011 and mailed to the address 

specified in the ADDRESSES section of 

this notice. 

ADDRESSES: You may mail nominations 

for membership to the following 

address: Centers for Medicare & 

Medicaid Services, Office of Clinical 

Standards and Quality, Attention: Maria 

Ellis, 7500 Security Boulevard, Mail 

Stop: South Building 3–02–01, 

Baltimore, MD 21244. 

FOR FURTHER INFORMATION CONTACT: 

Maria Ellis, Executive Secretary for the 

MEDCAC, Centers for Medicare & 

Medicaid Services, Office of Clinical 

Standards and Quality, Coverage and 

Analysis Group, S3–02–01, 7500 

Security Boulevard, Baltimore, MD 

21244 or contact Ms. Ellis by phone 

(410–786–0309) or via e-mail at 

Maria.Ellis@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

On December 14, 1998, we published 

a notice in the Federal Register (63 FR 

68780) announcing establishment of the 

Medicare Coverage Advisory Committee 

(MCAC). The Secretary signed the initial 

charter for the Medicare Coverage 

Advisory Committee on November 24, 

1998. On January 26, 2007 the Secretary 

published a notice in the Federal 

Register (72 FR 3853), changing the 

Committee’s name to the MEDCAC. The 

charter for the committee was recently 

renewed by the Secretary and will 

terminate on November 24, 2012, unless 

renewed again by the Secretary. 

The MEDCAC is governed by 

provisions of the Federal Advisory 

Committee Act, Public Law 92–463, as 

amended (5 U.S.C. App. 2), which sets 

forth standards for the formulation and 

use of advisory committees, and is 

authorized by section 222 of the Public 

Health Service Act as amended (42 

U.S.C. 217A). 

The MEDCAC consists of a pool of 

100 appointed members including: 6 

patient advocates, who are standard 

voting members, and 6 representatives 

of industry interests, who are nonvoting 

members. Members are selected from 

authorities in clinical medicine of all 

specialties, administrative medicine, 

public health, biologic and physical 

sciences, health care data and 

information management and analysis, 

patient advocacy, the economics of 

health care, medical ethics, and other 

related professions such as 

epidemiology and biostatistics, and 

methodology of trial design. 

The MEDCAC functions on a 

committee basis. The committee reviews 

and evaluates medical literature, 

reviews technology assessments, and 

examines data and information on the 

effectiveness and appropriateness of 

medical items and services that are 

covered or eligible for coverage under 

Medicare. The Committee works from 

an agenda provided by the Designated 

Federal Official that lists specific issues, 

and develops technical advice to assist 

us in determining reasonable and 

necessary applications of medical 

services and technology when we make 

national coverage decisions for 

Medicare. The Committee also advises 

CMS as part of Medicare’s ‘‘coverage 

with evidence development’’ activities. 

II. Provisions of the Notice 

As of June 2011, there will be 19 

terms of membership expiring, 2 of 

which are nonvoting industry 

representatives and 2 of which are 

voting patient advocates. 

Accordingly, we are requesting 

nominations for both voting and 

nonvoting members to serve on the 

MEDCAC. Nominees are selected based 

upon their individual qualifications and 

not as representatives of professional 

associations or societies. We have a 

special interest in ensuring that women, 

minority groups, and physically 

challenged individuals are adequately 

represented on the MEDCAC. Therefore, 

we encourage nominations of qualified 

candidates from these groups. 

All nominations must be 

accompanied by curricula vitae. 

Nomination packages must be sent to 

Maria Ellis at the address listed in the 

ADDRESSES section of this notice. 

Nominees for voting membership must 

also have expertise and experience in 

one or more of the following fields: 

• Clinical medicine of all specialties 

• Administrative medicine 

• Public health 

• Patient advocacy 

• Biologic and physical sciences 

• Health care data and information 

management and analysis 

• The economics of health care 

• Medical ethics 

• Other related professions such as 

epidemiology and biostatistics, and 

methodology of clinical trial design 

We are looking for experts in a 

number of fields. Our most critical 

needs are for experts in hematology; 

genomics; end of life care; Bayesian 

statistics; clinical epidemiology; clinical 

trial methodology; knee, hip, and other 

joint replacement surgery; 

ophthalmology; psychopharmacology; 

registries; rheumatology; screening and 

diagnostic testing analysis; and vascular 

surgery. We also need experts in 

biostatistics in clinical settings, 

cardiovascular epidemiology, dementia, 

endocrinology, geriatrics, gynecology, 

minority health, observational research 

design, stroke epidemiology, and 

women’s health. 

The nomination letter must include a 

statement that the nominee is willing to 

serve as a member of the MEDCAC and 

appears to have no conflict of interest 

that would preclude membership. We 

are requesting that all curricula vitae 

include the following: 

• Date of birth 

• Place of birth 

• Social security number 

• Title and current position 

• Professional affiliation 

• Home and business address 

• Telephone and fax numbers 

• E-mail address 

• List of areas of expertise 

In the nomination letter, we are 

requesting that the nominee specify 

whether they are applying for a voting 

patient advocate position, for another 

voting position, or as a nonvoting 

industry representative. Potential 

candidates will be asked to provide 

detailed information concerning such 

matters as financial holdings, 

consultancies, and research grants or 

contracts in order to permit evaluation 

of possible sources of conflict of 

interest. 

Members are invited to serve for 

overlapping 2-year terms. A member 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 241 / Thursday, December 16, 2010 / Notices 78707 

may serve after the expiration of the 

member’s term until a successor takes 

office. Any interested person may 

nominate one or more qualified persons. 

Self-nominations are also accepted. 

The current Secretary’s Charter for the 

MEDCAC is available on the CMS Web 

site at: http://www.cms.hhs.gov/FACA/ 

Downloads/medcaccharter.pdf, or you 

may obtain a copy of the charter by 

submitting a request to the contact listed 

in the FOR FURTHER INFORMATION

CONTACT section of this notice. 

Authority: 5 U.S.C. App. 2, section 

10(a)(1) and (a)(2). 

(Catalog of Federal Domestic Assistance 

Program No. 93.773, Medicare—Hospital 

Insurance; and Program No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program.) 

Dated: December 13, 2010. 

Barry M. Straube, 

CMS Chief Medical Officer, Director, Office 

of Clinical Standards and Quality, Centers 

for Medicare & Medicaid Services. 

[FR Doc. 2010–31642 Filed 12–15–10; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–1573–N] 

Medicare Program; First Semi-Annual 

Meeting of the Advisory Panel on 

Ambulatory Payment Classification 

Groups—February 28, 2011 Through 

March 2, 2011 

AGENCY: Centers for Medicare & 

Medicaid Services, Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: This notice announces the 

first semi-annual meeting of the 

Advisory Panel on Ambulatory Payment 

Classification (APC) Groups (the Panel) 

for 2011. The purpose of the Panel is to 

review the APC groups and their 

associated weights and to advise the 

Secretary of the Department of Health 

and Human Services (DHHS) (the 

Secretary) and the Administrator of the 

Centers for Medicare & Medicaid 

Services (CMS) (the Administrator) 

concerning the clinical integrity of the 

APC groups and their associated 

weights established under the Medicare 

hospital Outpatient Prospective 

Payment System (OPPS). We will 

consider the Panel’s advice as we 

prepare the proposed rule to update the 

Medicare hospital Outpatient 

Prospective Payment System (OPPS) for 

CY 2012. 

DATES: Meeting Dates: We are 

scheduling the first semi-annual 

meeting in 2011 for the following dates 

and times: 

• Monday, February 28, 2011, 1 p.m. to 

5 p.m. eastern standard time (e.s.t.) 

• Tuesday, March 1, 2011, 8 a.m. to 5 

p.m. (e.s.t.) 

• Wednesday, March 2, 2011, 8 a.m. to 

12 Noon (e.s.t.) 

Note 1: The times listed in this notice are 

approximate times; consequently, the 

meetings may last longer than listed in this 

notice, but it will not begin before the posted 

times. 

Note 2: If the Panel’s business concludes 

by COB on Tuesday (3/1/2011), there will be 

no meeting on Wednesday (3/2/2011). 

Deadlines 

Deadline for Hardcopy Comments 

(including the comment in 

electronic format)/Suggested 

Agenda Topics— 

5 p.m. (e.s.t.), Monday, February 7, 

2011. 

Deadline for Hardcopy Presentations, 

including the required electronic 

documents as discussed below— 

5 p.m. (e.s.t.), Monday, February 7, 

2011. 

Deadline for Attendance Registration— 

5 p.m. (e.s.t.), Wednesday, February 

23, 2011. 

Deadline for Special 

Accommodations— 

5 p.m. (e.s.t.), Wednesday, February 

23, 2011. 

Submission of Materials to the 

Designated Federal Officer (DFO) 

Because of staffing and resource 

limitations, we cannot accept written 

comments and presentations by FAX, 

nor can we print written comments and 

presentations received electronically for 

dissemination at the meeting. 

Only hardcopy comments and 

presentations can be reproduced for 

public dissemination. All hardcopy 

presentations must be accompanied by 

Form CMS–20017 (revised 01/07). The 

form is now available through the CMS 

Forms Web site. The Uniform Resource 

Locator (URL) for linking to this form is 

as follows: http://www.cms.hhs.gov/

cmsforms/downloads/cms20017.pdf. 

Presenters must use the most recent 

copy of CMS–20017 (updated 01/07) at 

the above URL. Additionally, presenters 

must clearly explain the action(s) that 

they are requesting CMS to take in the 

appropriate section of the form. They 

must also clarify their relationship to 

the organization that they represent in 

the presentation. 

(Note: Issues that are vague, or that are 

outside the scope of the APC Panel’s 

purpose, will not be considered for 

presentations and comments. There will 

be no exceptions to this rule. We 

appreciate your cooperation on this 

matter.) 

We are also requiring electronic 

versions of the written comments and 

presentations, in addition to the 

hardcopies. 

In summary, presenters and/or 

commenters must do the following: 

• Send both electronic and hardcopy 

versions of their presentations and 

written comments by the prescribed 

deadlines. 

• Send electronic transmissions to the 

e-mail address below. 

• Do not send pictures of patients in 

any of the documents unless their faces 

have been blocked out. 

• Do not send documents 

electronically that have been archived. 

• Mail (or send by courier) to the DFO 

all hardcopies, accompanied by Form 

CMS–20017 (revised 01/07), if they are 

presenting, as specified in the FOR

FURTHER INFORMATION CONTACT section of 

this notice. 

• Commenters are not required to 

send Form CMS–20017 with their 

written comments. 

ADDRESSES: The meeting will be held in 

the Auditorium, CMS Central Office, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

FOR FURTHER INFORMATION CONTACT: 

Shirl Ackerman-Ross, DFO, CMS, CM, 

HAPG, DOC, 7500 Security Boulevard, 

Mail Stop C4–05–17, Baltimore, MD 

21244–1850. Phone: (410) 786–4474. 

E-mail: SAckermanross@cms.hhs.gov. 

(Note:) We recommend that you advise 

couriers of the following information: 

When delivering hardcopies of 

presentations to CMS, if no one answers 

at the above phone number, call (410) 

786–4532 or (410) 786–9316.) 

The e-mail address for comments, 

presentations, and registration requests 

is CMS APCPanel@cms.hhs.gov. 

(Note: There is NO underscore in this email address; there is a SPACE between 

CMS and APCPanel.) 

News media representatives must 

contact our Public Affairs Office at (202) 

690–6145. 

Advisory Committees’ Information 

Lines: The phone numbers for the CMS 

Federal Advisory Committee Hotline are 

1–877–449–5659 (toll free) and (410) 

786–9379 (local). 

Web Sites: Access the CMS Web site 

at: http://www.cms.hhs.gov/FACA/05_

AdvisoryPanelonAmbulatoryPayment

ClassificationGroups.asp#TopOfPage to 

obtain the following information: 

(Note: There is an UNDERSCORE after 

FACA/05(like this_); there is no space.) 


srobinson on DSKHWCL6B1PROD with NOTICES